C. Eekman

P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy

P. Sonneveld, J. Lankelma, B. Löwenberg, 2000, Leukemia.

Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.

P. Sonneveld, J. Lankelma, G. Ossenkoppele, 1996, Blood.

Platelet: transporter of vascular endothelial growth factor.

H. Verheul, C. Folman, H. Pinedo, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?

P. Sonneveld, R. Pieters, J. Lankelma, 1999, Leukemia.

Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia

J. Lankelma, G. Schuurhuis, G. Ossenkoppele, 1997, Leukemia.

Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.

R. Pieters, J. Baak, J. Lankelma, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.

H. M. Pinedo, J. Lankelma, G. Schuurhuis, 1993, British Journal of Cancer.

Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain.

K. Hoekman, H. M. Pinedo, M. Poot, 1997, British Journal of Cancer.